Literature DB >> 27089237

Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.

Douglas A Corley1, Jennifer S Haas2, Sarah Kobrin3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27089237      PMCID： PMC4920648          DOI： 10.1001/jama.2016.3067

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.

Authors:  A Blythe Ryerson; Jacqueline Miller; Christie R Eheman
Journal:  Cancer Causes Control       Date:  2015-03-10       Impact factor: 2.506

2.  Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Authors:  Jessica Chubak; Michael P Garcia; Andrea N Burnett-Hartman; Yingye Zheng; Douglas A Corley; Ethan A Halm; Amit G Singal; Carrie N Klabunde; Chyke A Doubeni; Aruna Kamineni; Theodore R Levin; Joanne E Schottinger; Beverly B Green; Virginia P Quinn; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254
  2 in total
  5 in total

1.  Social Disadvantage, Healthcare Utilization, and Colorectal Cancer Screening: Leveraging Longitudinal Patient Address and Health Records Data.

Authors:  Amy E Hughes; Jasmin A Tiro; Bijal A Balasubramanian; Celette Sugg Skinner; Sandi L Pruitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-22       Impact factor: 4.254

2.  Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristics.

Authors:  Jennifer S Haas; David Cheng; Liyang Yu; Steven J Atlas; Cheryl Clark; Sarah Feldman; Michelle I Silver; Aruna Kamineni; Jessica Chubak; Gaia Pocobelli; Jasmin A Tiro; Sarah C Kobrin
Journal:  Prev Med       Date:  2021-11-08       Impact factor: 4.018

3.  Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda.

Authors:  Elisabeth F Beaber; Aruna Kamineni; Andrea N Burnett-Hartman; Brian Hixon; Sarah C Kobrin; Christopher I Li; Malia Oliver; Katharine A Rendle; Celette Sugg Skinner; Kaitlin Todd; Yingye Zheng; Rebecca A Ziebell; Erica S Breslau; Jessica Chubak; Douglas A Corley; Robert T Greenlee; Jennifer S Haas; Ethan A Halm; Stacey Honda; Christine Neslund-Dudas; Debra P Ritzwoller; Joanne E Schottinger; Jasmin A Tiro; Anil Vachani; V Paul Doria-Rose
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

4.  Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study.

Authors:  Carolyn M Rutter; Jane J Kim; Reinier G S Meester; Brian L Sprague; Emily A Burger; Ann G Zauber; Mehmet Ali Ergun; Nicole G Campos; Chyke A Doubeni; Amy Trentham-Dietz; Stephen Sy; Oguzhan Alagoz; Natasha Stout; Iris Lansdorp-Vogelaar; Douglas A Corley; Anna N A Tosteson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-17       Impact factor: 4.254

5.  Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.

Authors:  Aruna Kamineni; Jasmin A Tiro; Elisabeth F Beaber; Michael J Silverberg; Cosette M Wheeler; Chun R Chao; Jessica Chubak; Celette Sugg Skinner; Douglas A Corley; Jane J Kim; Bijal A Balasubramanian; V Paul Doria-Rose
Journal:  Int J Cancer       Date:  2018-12-20       Impact factor: 7.396
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.